Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × tislelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 9 Advanced Solid Tumor 6 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Stomach Neoplasms 2 Rectal Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Follicular 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Advanced Solid Tumour 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solid Tumor 1 Simpson-Golabi-Behmel syndrome 1 Pseudomyxoma Peritonei 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasm, Residual 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Metastatic Solid Tumors 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

Biopsy 4 fludarabine 3 Cyclophosphamide 3 romidepsin 2 pembrolizumab 2 mogamulizumab 2 Specimen Handling 2 tazemetostat 1 talimogene laherparepvec 1 ruxolitinib 1 hypericin 1 fludarabine phosphate 1 cc-486 1 belinostat 1 Valganciclovir 1 Urine Specimen Collection 1 Therapeutics 1 TNTCFP protein 1 Spinal Puncture 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 MEDI-570 1 Light 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡